JOSEPH BIEDERMAN
Medical Practice at Boylston St, Brookline, MA
License number
Florida 113100
Issued Date
May 23, 2012
Effective Date
May 23, 2012
Expiration Date
Jan 31, 2018
Category
Health Care
Type
Medical Doctor
Address
Address
523 Boylston St, Brookline, MA 02445
Phone
(617) 566-5329
Personal information
See more information about JOSEPH BIEDERMAN at radaris.comName
Address
Phone
523 Boylston St, Brookline, MA 02445
523 Boylston St, Brookline, MA 02445
Professional information
See more information about JOSEPH BIEDERMAN at trustoria.com
Methods And Compositions To Prevent Addiction
Methods And Compositions To Prevent Addiction
US Patent:
2012030, Nov 29, 2012
Filed:
Aug 13, 2010
Appl. No.:
13/389959
Inventors:
Pradeep G. Bhide - Peabody MA, US
Jinmin Zhu - Allston MA, US
Thomas J. Spencer - Carlisle MA, US
Joseph Biederman - Brookline MA, US
Jinmin Zhu - Allston MA, US
Thomas J. Spencer - Carlisle MA, US
Joseph Biederman - Brookline MA, US
Assignee:
THE GENERAL HOSPITAL CORPORATION - Boston MA
International Classification:
A61K 31/485, A61P 25/04
US Classification:
514282
Abstract:
Disclosed herein is a method of reducing or preventing the development of aversion to a CNS stimulant in a subject comprising, administering a therapeutic amount of the neurological stimulant and administering an antagonist of the kappa opioid receptor, to thereby reduce or prevent the development of aversion to the CNS stimulant in the subject. Also disclosed is a method of reducing or preventing the development of addiction to a CNS stimulant in a subject, comprising, administering the CNS stimulant and administering a mu opioid receptor antagonist to thereby reduce or prevent the development of addiction to the CNS stimulant in the subject. Also disclosed are pharmaceutical compositions comprising a central nervous system stimulant and an opioid receptor antagonist. Examples of central nervous system stimulants (such as methylphenidate) and opioid receptor antagonists (such as naltrexone) are provided.
Methods And Compositions To Prevent Addiction
Methods And Compositions To Prevent Addiction
US Patent:
2013028, Oct 31, 2013
Filed:
Jun 24, 2013
Appl. No.:
13/924815
Inventors:
Jinmin Zhu - Allston MA, US
Thomas J. Spencer - Carlisle MA, US
Joseph Biederman - Brookline MA, US
Thomas J. Spencer - Carlisle MA, US
Joseph Biederman - Brookline MA, US
International Classification:
A61K 31/485, A61K 31/4458
US Classification:
514282, 514317, 514654, 514618, 514279
Abstract:
Disclosed herein is a method of reducing or preventing the development of aversion to a CNS stimulant in a subject comprising, administering a therapeutic amount of the neurological stimulant and administering an antagonist of the kappa opioid receptor, to thereby reduce or prevent the development of aversion to the CNS stimulant in the subject. Also disclosed is a method of reducing or preventing the development of addiction to a CNS stimulant in a subject, comprising, administering the CNS stimulant and administering a mu opioid receptor antagonist to thereby reduce or prevent the development of addiction to the CNS stimulant in the subject. Also disclosed are pharmaceutical compositions comprising a central nervous system stimulant and an opioid receptor antagonist. Examples of central nervous system stimulants (such as methylphenidate) and opioid receptor antagonists (such as naltrexone) are provided.